EUCTR2014-004872-47-SE进行中（未招募）1 期
The effects of COX-inhibiting drugs on skeletal muscle adaptations to resistance exercise in healthy adults.
Karolinska Institutet, Department of Laboratory Medicine, Clinical Physiology C1:82,Karolinska Univ. Hosp., Huddinge0 个研究点开始时间: 2015年5月22日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •men / women age 18-35
- •Physically active 1-4 hrs per week
- •Signed informed consent
- •Deemed healthy after anamnesis and health declaration
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Lower leg injury
- •Sensitivity to any of the prescribed medications
- •Ulcer or gastrointestinal problems
- •Liver dysfunction
- •Autoimmune disease
- •Kidney disease
- •Hypertension
- •Established cardiovascular disease
- •Anamnesia of substantial bleedings
- •Consumption of medications that counteracts or act synergistically with the prescribed drugs
- •Takes part in another research study
研究者
相似试验
已完成
2 期
The Effects of COX-inhibiting Drugs on Skeletal Muscle Adaptations to Resistance Exercise in Healthy AdultsSkeletal Muscle Mass RegulationNCT02531451Karolinska Institutet34
已完成
不适用
Effect of COX-2 selective inhibitor to synovial fluids and synovial tissues of osteoarthritis of the knee at total knee replacement.JPRN-UMIN000017481Department of Orthopaedic Surgery, Hokkaido University Graduate School of Medicine30
尚未招募
不适用
Effect of combined COX-1 and COX-2 inhibition on platelet aggregation in-vivoenhanced clottingthrombosis1003446810014523NL-OMON30233Vrije Universiteit Medisch Centrum20
已完成
不适用
The clinical effect of Cyclooxygenase (COX)-2 selective inhibitors on pollakisuria and lumbar- abdominal pain in patients with prostate cancer who undergo interstitial seed implantation - Randomized control trialprostate cancerJPRN-UMIN000003649ara Medical University150
撤回
2 期
COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast CancerEstrogen Receptor-positive Breast CancerBreast CancerNCT04038489University of Virginia